Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Smoldering Multiple Myeloma 1Ovarian Neoplasms 1Multiple Myeloma 1Hemangioma, Capillary 1Hemangioma 1Hemangioblastoma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Colposcopy 17Methods 14Early Intervention, Educational 12Cisplatin 12Brachytherapy 11Human Papillomavirus DNA Tests 10Blood Specimen Collection 10Educational Status 9Biopsy 8Standard of Care 7Radiotherapy 7Patient Navigation 7Papanicolaou Test 7Magnetic Resonance Spectroscopy 7Vaginal Smears 6Sentinel Lymph Node Biopsy 6Mass Screening 6Counseling 6Acetic Acid 6Watchful Waiting 5Surveys and Questionnaires 5Radiotherapy, Intensity-Modulated 5Therapeutics 4Specimen Handling 4Radiation Dose Hypofractionation 4Practice Guidelines as Topic 4Paclitaxel 4Transurethral Resection of Prostate 3Radiation 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Uterine Cervical Neoplasms × Propranolol × Clear all
NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡